| Oral and Maxillofacial Pathology | Lifetime | 162 | BR 6 | 98.93 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 263 | BR 4 | 98.24 |
| Tumors and Oncological Cases | Lifetime | 255 | BR 6 | 97.61 |
| Ear and Head Tumors | Lifetime | 215 | BR 5 | 97.67 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 448 | BR 7 | 97.26 |
| Oral Health Pathology and Treatment | Lifetime | 329 | BR 11 | 97.08 |
| Oral and Craniofacial Lesions | Lifetime | 62 | BR 10 | 94.38 |
| Soft tissue tumor case studies | Lifetime | 283 | BR 4 | 96.14 |
| Oral and gingival health research | Lifetime | 537 | BR 38 | 93.65 |
| Vascular Malformations and Hemangiomas | Lifetime | 837 | BR 10 | 89.62 |
| Oral health in cancer treatment | Lifetime | 789 | BR 72 | 86.89 |
| HIV/AIDS oral health manifestations | Lifetime | 652 | BR 52 | 87.76 |
| Soft tissue tumors and treatment | Lifetime | 394 | BR 9 | 80.96 |
| Teratomas and Epidermoid Cysts | Lifetime | 868 | BR 12 | 74.30 |
| Oral and Maxillofacial Pathology | 2021-2025 | 6 | BR 1 | 99.43 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 17 | BR 2 | 98.22 |
| Tumors and Oncological Cases | 2021-2025 | 20 | BR 1 | 96.52 |
| Oral Health Pathology and Treatment | 2021-2025 | 37 | BR 3 | 96.34 |
| Ear and Head Tumors | 2021-2025 | 32 | BR 1 | 95.67 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 86 | BR 3 | 94.83 |
| Head and Neck Cancer Studies | 2021-2025 | 324 | BR 4 | 95.19 |
| Cancer Diagnosis and Treatment | 2021-2025 | 154 | BR 7 | 90.57 |
| Soft tissue tumor case studies | 2021-2025 | 87 | BR 1 | 87.32 |
| dental development and anomalies | 2021-2025 | 292 | BR 22 | 85.34 |
| Viral-associated cancers and disorders | 2021-2025 | 890 | BR 7 | 78.39 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 835 | BR 2 | 71.01 |
| Oral and Craniofacial Lesions | 2021-2025 | 98 | BR 29 | 70.32 |
| Vascular Malformations and Hemangiomas | 2021-2025 | 481 | BR 2 | 67.78 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 623 | BR 7 | 66.90 |
| Oral health in cancer treatment | 2021-2025 | 584 | BR 91 | 65.88 |
| Oral and gingival health research | 2021-2025 | 489 | BR 42 | 65.76 |
| Dermatological and COVID-19 studies | 2021-2025 | 585 | BR 32 | 57.07 |
| Teratomas and Epidermoid Cysts | 2021-2025 | 203 | BR 14 | 53.14 |
| Histiocytic Disorders and Treatments | 2021-2025 | 509 | BR 4 | 50.82 |
| Osteomyelitis and Bone Disorders Research | 2021-2025 | 349 | BR 15 | 35.22 |
| HIV/AIDS oral health manifestations | 2021-2025 | 956 | BR 169 | 28.61 |
